Back
Verisk Analytics Vs. CRISPR Therapeutics AG Industry Stock Comparison
Buy
63
VRSK
Verisk Analytics
Last Price:
$285.95
Seasonality Move:
6.81%
Sell
34
CRSP
CRISPR Therapeutics AG
Last Price:
$38.28
Seasonality Move:
20.1%
Buy
63
Verisk Analytics (VRSK)
is a Buy
Is Verisk Analytics a Buy, Sell or Hold?
-
The current Verisk Analytics [VRSK] share price is $286.05. The Score for VRSK is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
-
VRSK is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
34
CRISPR Therapeutics AG (CRSP)
is a Sell
Is CRISPR Therapeutics AG a Buy, Sell or Hold?
-
The current CRISPR Therapeutics AG [CRSP] share price is $38.27. The Score for CRSP is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
-
CRSP is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
VRSK Stock Price Chart
What is Verisk Analytics's stock price today?
-
The Verisk Analytics share price today is $286.05Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VRSK is experiencing slight buying pressure.
CRSP Stock Price Chart
What is CRISPR Therapeutics AG's stock price today?
-
The CRISPR Therapeutics AG share price today is $38.27The current trend is moderately bullish and CRSP is experiencing slight selling pressure.
VRSK Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.72 | Sell |
| Relative Strength Index (14 RSI): | 45.86 | Sell |
| Chaikin Money Flow: | 234468 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (284.2 - 297.14) | Sell |
| Bollinger Bands (100): | (279.39 - 295.29) | Sell |
CRSP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 5.07 | Buy |
| Relative Strength Index (14 RSI): | 50.42 | Buy |
| Chaikin Money Flow: | -525417 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (33.9 - 40.02) | Buy |
| Bollinger Bands (100): | (37.22 - 46.82) | Sell |
VRSK Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 290.21 | Sell |
| 20-day SMA: | 290.98 | Sell |
| 50-day SMA: | 292.05 | Sell |
| 200-day SMA: | 279.89 | Buy |
| 8-day EMA: | 289.15 | Sell |
| 20-day EMA: | 290.13 | Sell |
| 50-day EMA: | 289.9 | Sell |
| 200-day EMA: | 278.29 | Buy |
CRSP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 38.43 | Sell |
| 20-day SMA: | 36.1 | Buy |
| 50-day SMA: | 40.71 | Sell |
| 200-day SMA: | 45.82 | Sell |
| 8-day EMA: | 38.12 | Buy |
| 20-day EMA: | 34.63 | Buy |
| 50-day EMA: | 24.01 | Buy |
| 200-day EMA: | 8.5 | Buy |
Verisk Analytics Earnings Growth & VRSK Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.18 per share, an increase next quarter of $0.10 per share, an increase this year of $0.40 per share, and an increase next year of $0.86 per share.
CRISPR Therapeutics AG Earnings Growth & CRSP Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.15 per share, an increase next quarter of $0.04 per share, an increase this year of $0.16 per share, and an increase next year of $0.94 per share.
Verisk Analytics Technical Analysis
| Apr 11 | Apr 14 | Apr 15 | Apr 16 | Apr 17 | Apr 21 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 11 | 14 | 15 | 16 | 17 | 21 | 22 | 23 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
CRISPR Therapeutics AG Technical Analysis
| Apr 11 | Apr 14 | Apr 15 | Apr 16 | Apr 17 | Apr 21 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 11 | 14 | 15 | 16 | 17 | 21 | 22 | 23 | 24 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||